TCI Wealth Advisors’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

TCI Wealth Advisors’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-119	Closed	-$4K	–	2681
2021 Q2	$4K	Buy	119 +53	+80%	+$1.35K	﹤0.01%	1681
2021 Q1	$2K	Buy	+66	New	+$2K	﹤0.01%	2003

TCI Wealth Advisors's CNST Position: Q3 2021 in Review

TCI Wealth Advisors sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 119 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in CNST in Q1 2021 and held it in 2 quarters. The position peaked at $4K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

TCI Wealth Advisors reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
TCI Wealth Advisors sold 119 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $4K.
TCI Wealth Advisors first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2021 and held it in 2 quarters.
TCI Wealth Advisors's Constellation Pharmaceuticals, Inc. position peaked at $4K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on TCI Wealth Advisors's 13F filing for Q3 2021, filed 29 Oct 2021.